Press Releases

All
Smart Stories
All
Press Releases
All
Factsheets

Smart Immune receives $5 million investment to further its thymus-empowered ProTcell therapy platform

April 17, 2023

Smart Immune receives €2.5m grant and €15m equity investment commitment from the European Innovation Council (EIC) via the EIC Accelerator

March 30, 2023

Smart Immune is selected for the first cohort of the French Tech Health20 program

March 24, 2023

1st leukemia patient dosed with SMART101 at MSK

January 23, 2023

Smart Immune appoints world-class Clinical Advisory Board

November 21, 2022

Smart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancers

October 13, 2022